A carregar...
Bleeding in patients receiving non-vitamin K oral anticoagulants: clinical trial evidence
In optimizing anticoagulation therapy, it is essential to balance treatment efficacy with the major adverse effect of anticoagulant treatment, bleeding risk. This narrative review examines the efficacy and safety of the non-vitamin K antagonist oral anticoagulants (NOACs) dabigatran, rivaroxaban, ap...
Na minha lista:
| Publicado no: | Ther Adv Cardiovasc Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6266250/ https://ncbi.nlm.nih.gov/pubmed/30270775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944718801554 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|